{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:01:41Z","timestamp":1790751701471,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,17]],"date-time":"2018-08-17T00:00:00Z","timestamp":1534464000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,8,17]],"date-time":"2018-08-17T00:00:00Z","timestamp":1534464000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The deposition of misfolded proteins, including amyloid beta plaques and neurofibrillary tangles is the histopathological hallmark of Alzheimer\u2019s disease (AD). The glymphatic system, a brain-wide network of perivascular pathways that supports interstitial solute clearance, is dependent upon expression of the perivascular astroglial water channel aquaporin-4 (AQP4). Impairment of glymphatic function in the aging rodent brain is associated with reduced perivascular AQP4 localization, and in human subjects, reduced perivascular AQP4 localization is associated with AD diagnosis and pathology. Using human transcriptomic data, we demonstrate that expression of perivascular astroglial gene products dystroglycan (<jats:italic>DAG1<\/jats:italic>), dystrobrevin (<jats:italic>DTNA<\/jats:italic>) and alpha-syntrophin (<jats:italic>SNTA1<\/jats:italic>), are associated with dementia status and phosphorylated tau (P-tau) levels in temporal cortex. Gene correlation analysis reveals altered expression of a cluster of potential astrocytic endfoot components in human subjects with dementia, with increased expression associated with temporal cortical P-tau levels. The association between perivascular astroglial gene products, including <jats:italic>DTNA<\/jats:italic> and megalencephalic leukoencephalopathy with subcortical cysts 1 (<jats:italic>MLC1<\/jats:italic>) with AD status was confirmed in a second human transcriptomic dataset and in human autopsy tissue by Western blot. This suggests changes in the astroglial endfoot domain may underlie vulnerability to protein aggregation in AD.<\/jats:p>","DOI":"10.1038\/s41598-018-30779-x","type":"journal-article","created":{"date-parts":[[2018,8,13]],"date-time":"2018-08-13T13:29:32Z","timestamp":1534166972000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":71,"title":["Transcriptional network analysis of human astrocytic endfoot genes reveals region-specific associations with dementia status and tau pathology"],"prefix":"10.1038","volume":"8","author":[{"given":"Matthew J.","family":"Simon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie X.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles F.","family":"Murchison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie E.","family":"Roese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin L.","family":"Boespflug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall L.","family":"Woltjer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6910-0080","authenticated-orcid":false,"given":"Jeffrey J.","family":"Iliff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,17]]},"reference":[{"key":"30779_CR1","doi-asserted-by":"publisher","first-page":"a006189","DOI":"10.1101\/cshperspect.a006189","volume":"1","author":"A Serrano-Pozo","year":"2011","unstructured":"Serrano-Pozo, A., Frosch, M. P., Masliah, E. & Hyman, B. T. Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med 1, a006189, https:\/\/doi.org\/10.1101\/cshperspect.a006189 (2011).","journal-title":"Cold Spring Harb Perspect Med"},{"key":"30779_CR2","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.neuron.2008.02.003","volume":"58","author":"JR Cirrito","year":"2008","unstructured":"Cirrito, J. R. et al. Endocytosis is required for synaptic activity-dependent release of amyloid-beta in vivo. Neuron 58, 42\u201351, https:\/\/doi.org\/10.1016\/j.neuron.2008.02.003 (2008).","journal-title":"Neuron"},{"key":"30779_CR3","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1126\/science.1197623","volume":"330","author":"KG Mawuenyega","year":"2010","unstructured":"Mawuenyega, K. G. et al. Decreased clearance of CNS beta-amyloid in Alzheimer\u2019s disease. Science (New York, N.Y.) 330, 1774, https:\/\/doi.org\/10.1126\/science.1197623 (2010).","journal-title":"Science (New York, N.Y.)"},{"key":"30779_CR4","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1002\/ana.24454","volume":"78","author":"BW Patterson","year":"2015","unstructured":"Patterson, B. W. et al. Age and amyloid effects on human central nervous system amyloid-beta kinetics. Annals of neurology 78, 439\u2013453, https:\/\/doi.org\/10.1002\/ana.24454 (2015).","journal-title":"Annals of neurology"},{"key":"30779_CR5","doi-asserted-by":"publisher","first-page":"15317","DOI":"10.1074\/jbc.M110.209296","volume":"286","author":"JL Guo","year":"2011","unstructured":"Guo, J. L. & Lee, V. M. Seeding of normal Tau by pathological Tau conformers drives pathogenesis of Alzheimer-like tangles. J Biol Chem 286, 15317\u201315331, https:\/\/doi.org\/10.1074\/jbc.M110.209296 (2011).","journal-title":"J Biol Chem"},{"key":"30779_CR6","doi-asserted-by":"publisher","first-page":"e31302","DOI":"10.1371\/journal.pone.0031302","volume":"7","author":"L Liu","year":"2012","unstructured":"Liu, L. et al. Trans-synaptic spread of tau pathology in vivo. Plos One 7, e31302, https:\/\/doi.org\/10.1371\/journal.pone.0031302 (2012).","journal-title":"Plos One"},{"key":"30779_CR7","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1084\/jem.20131685","volume":"211","author":"K Yamada","year":"2014","unstructured":"Yamada, K. et al. Neuronal activity regulates extracellular tau in vivo. J Exp Med 211, 387\u2013393, https:\/\/doi.org\/10.1084\/jem.20131685 (2014).","journal-title":"J Exp Med"},{"key":"30779_CR8","doi-asserted-by":"publisher","first-page":"147ra111","DOI":"10.1126\/scitranslmed.3003748","volume":"4","author":"JJ Iliff","year":"2012","unstructured":"Iliff, J. J. et al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid beta. Sci Transl Med 4, 147ra111, https:\/\/doi.org\/10.1126\/scitranslmed.3003748 (2012).","journal-title":"Sci Transl Med"},{"key":"30779_CR9","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13024-015-0056-1","volume":"10","author":"Z Xu","year":"2015","unstructured":"Xu, Z. et al. Deletion of aquaporin-4 in APP\/PS1 mice exacerbates brain Abeta accumulation and memory deficits. Mol Neurodegener 10, 58, https:\/\/doi.org\/10.1186\/s13024-015-0056-1 (2015).","journal-title":"Mol Neurodegener"},{"key":"30779_CR10","doi-asserted-by":"publisher","first-page":"16180","DOI":"10.1523\/JNEUROSCI.3020-14.2014","volume":"34","author":"JJ Iliff","year":"2014","unstructured":"Iliff, J. J. et al. Impairment of glymphatic pathway function promotes tau pathology after traumatic brain injury. J Neurosci 34, 16180\u201316193, https:\/\/doi.org\/10.1523\/jneurosci.3020-14.2014 (2014).","journal-title":"J Neurosci"},{"key":"30779_CR11","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1002\/ana.24271","volume":"76","author":"BT Kress","year":"2014","unstructured":"Kress, B. T. et al. Impairment of paravascular clearance pathways in the aging brain. Ann Neurol 76, 845\u2013861, https:\/\/doi.org\/10.1002\/ana.24271 (2014).","journal-title":"Ann Neurol"},{"key":"30779_CR12","doi-asserted-by":"publisher","first-page":"205846011560963","DOI":"10.1177\/2058460115609635","volume":"4","author":"PK Eide","year":"2015","unstructured":"Eide, P. K. & Ringstad, G. MRI with intrathecal MRI gadolinium contrast medium administration: a possible method to assess glymphatic function in human brain. Acta Radiol Open 4, 2058460115609635, https:\/\/doi.org\/10.1177\/2058460115609635 (2015).","journal-title":"Acta Radiol Open"},{"key":"30779_CR13","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1093\/brain\/awx191","volume":"140","author":"G Ringstad","year":"2017","unstructured":"Ringstad, G., Vatnehol, S. A. S. & Eide, P. K. Glymphatic MRI in idiopathic normal pressure hydrocephalus. Brain: a journal of neurology 140, 2691\u20132705, https:\/\/doi.org\/10.1093\/brain\/awx191 (2017).","journal-title":"Brain: a journal of neurology"},{"key":"30779_CR14","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1001\/jamaneurol.2016.4370","volume":"74","author":"DM Zeppenfeld","year":"2017","unstructured":"Zeppenfeld, D. M. et al. Association of Perivascular Localization of Aquaporin-4 With Cognition and Alzheimer Disease in Aging Brains. JAMA neurology 74, 91\u201399, https:\/\/doi.org\/10.1001\/jamaneurol.2016.4370 (2017).","journal-title":"JAMA neurology"},{"key":"30779_CR15","unstructured":"Allen Institute for Brain Science. Aging, Dementia and TBI. Available from, http:\/\/aging.brain-map.org\/ (2016)."},{"key":"30779_CR16","unstructured":"Allen Institute for Brain Science. Allen Cell Types Database. Available from, http:\/\/celltypes.brain-map.org\/ (2015)."},{"key":"30779_CR17","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.neuron.2015.11.013","volume":"89","author":"Y Zhang","year":"2016","unstructured":"Zhang, Y. et al. Purification and Characterization of Progenitor and Mature Human Astrocytes Reveals Transcriptional and Functional Differences with Mouse. Neuron 89, 37\u201353, https:\/\/doi.org\/10.1016\/j.neuron.2015.11.013 (2016).","journal-title":"Neuron"},{"key":"30779_CR18","doi-asserted-by":"publisher","unstructured":"Simon, M. J., Murchison, C. & Iliff, J. J. A transcriptome-based assessment of the astrocytic dystrophin-associated complex in the developing human brain. Journal of neuroscience research, https:\/\/doi.org\/10.1002\/jnr.24082 (2017).","DOI":"10.1002\/jnr.24082"},{"key":"30779_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-02505-6","volume":"7","author":"ZA Zhao","year":"2017","unstructured":"Zhao, Z. A. et al. Perivascular AQP4 dysregulation in the hippocampal CA1 area after traumatic brain injury is alleviated by adenosine A2A receptor inactivation. Sci Rep 7, 2254, https:\/\/doi.org\/10.1038\/s41598-017-02505-6 (2017).","journal-title":"Sci Rep"},{"key":"30779_CR20","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1152\/physrev.00011.2013","volume":"93","author":"EA Nagelhus","year":"2013","unstructured":"Nagelhus, E. A. & Ottersen, O. P. Physiological roles of aquaporin-4 in brain. Physiol Rev 93, 1543\u20131562, https:\/\/doi.org\/10.1152\/physrev.00011.2013 (2013).","journal-title":"Physiol Rev"},{"key":"30779_CR21","doi-asserted-by":"publisher","unstructured":"Burfeind, K. G. et al. The effects of noncoding aquaporin-4 single-nucleotide polymorphisms on cognition and functional progression of Alzheimer\u2019s disease. Alzheimer\u2019s & Dementia: Translational Research & Clinical Interventions 3, 348\u2013359, https:\/\/doi.org\/10.1016\/j.trci.2017.05.001.","DOI":"10.1016\/j.trci.2017.05.001"},{"key":"30779_CR22","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/glia.23092","volume":"65","author":"J Langer","year":"2017","unstructured":"Langer, J. et al. Rapid sodium signaling couples glutamate uptake to breakdown of ATP in perivascular astrocyte endfeet. Glia 65, 293\u2013308, https:\/\/doi.org\/10.1002\/glia.23092 (2017).","journal-title":"Glia"},{"key":"30779_CR23","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1002\/cne.23450","volume":"522","author":"AE Schreiner","year":"2014","unstructured":"Schreiner, A. E. et al. Laminar and subcellular heterogeneity of GLAST and GLT-1 immunoreactivity in the developing postnatal mouse hippocampus. The Journal of comparative neurology 522, 204\u2013224, https:\/\/doi.org\/10.1002\/cne.23450 (2014).","journal-title":"The Journal of comparative neurology"},{"key":"30779_CR24","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s00441-014-1837-5","volume":"357","author":"G Flugge","year":"2014","unstructured":"Flugge, G., Araya-Callis, C., Garea-Rodriguez, E., Stadelmann-Nessler, C. & Fuchs, E. NDRG2 as a marker protein for brain astrocytes. Cell and tissue research 357, 31\u201341, https:\/\/doi.org\/10.1007\/s00441-014-1837-5 (2014).","journal-title":"Cell and tissue research"},{"key":"30779_CR25","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s00401-007-0247-0","volume":"114","author":"I Boor","year":"2007","unstructured":"Boor, I. et al. MLC1 is associated with the dystrophin-glycoprotein complex at astrocytic endfeet. Acta Neuropathol 114, 403\u2013410, https:\/\/doi.org\/10.1007\/s00401-007-0247-0 (2007).","journal-title":"Acta Neuropathol"},{"key":"30779_CR26","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/nm.3457","volume":"20","author":"JL Guo","year":"2014","unstructured":"Guo, J. L. & Lee, V. M. Cell-to-cell transmission of pathogenic proteins in neurodegenerative diseases. Nat Med 20, 130\u2013138, https:\/\/doi.org\/10.1038\/nm.3457 (2014).","journal-title":"Nat Med"},{"key":"30779_CR27","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1002\/ana.24066","volume":"75","author":"A Recasens","year":"2014","unstructured":"Recasens, A. et al. Lewy body extracts from Parkinson disease brains trigger alpha-synuclein pathology and neurodegeneration in mice and monkeys. Annals of neurology 75, 351\u2013362, https:\/\/doi.org\/10.1002\/ana.24066 (2014).","journal-title":"Annals of neurology"},{"key":"30779_CR28","doi-asserted-by":"publisher","first-page":"12845","DOI":"10.1074\/jbc.M808759200","volume":"284","author":"B Frost","year":"2009","unstructured":"Frost, B., Jacks, R. L. & Diamond, M. I. Propagation of tau misfolding from the outside to the inside of a cell. J Biol Chem 284, 12845\u201312852, https:\/\/doi.org\/10.1074\/jbc.M808759200 (2009).","journal-title":"J Biol Chem"},{"key":"30779_CR29","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/embor.2013.15","volume":"14","author":"AM Pooler","year":"2013","unstructured":"Pooler, A. M., Phillips, E. C., Lau, D. H., Noble, W. & Hanger, D. P. Physiological release of endogenous tau is stimulated by neuronal activity. EMBO Rep 14, 389\u2013394, https:\/\/doi.org\/10.1038\/embor.2013.15 (2013).","journal-title":"EMBO Rep"},{"key":"30779_CR30","doi-asserted-by":"publisher","unstructured":"Miller, J. A. et al. Neuropathological and transcriptomic characteristics of the aged brain. Elife 6, https:\/\/doi.org\/10.7554\/eLife.31126 (2017).","DOI":"10.7554\/eLife.31126"},{"key":"30779_CR31","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1212\/WNL.41.4.479","volume":"41","author":"SS Mirra","year":"1991","unstructured":"Mirra, S. S. et al. The Consortium to Establish a Registry for Alzheimer\u2019s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer\u2019s disease. Neurology 41, 479\u2013486 (1991).","journal-title":"Neurology"},{"key":"30779_CR32","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1093\/cercor\/bht101","volume":"24","author":"M Hokama","year":"2014","unstructured":"Hokama, M. et al. Altered expression of diabetes-related genes in Alzheimer\u2019s disease brains: the Hisayama study. Cereb Cortex 24, 2476\u20132488, https:\/\/doi.org\/10.1093\/cercor\/bht101 (2014).","journal-title":"Cereb Cortex"},{"key":"30779_CR33","doi-asserted-by":"crossref","unstructured":"Braak, H. & Braak, E. Staging of Alzheimer\u2019s disease-related neurofibrillary changes. Neurobiol Aging 16, 271\u2013278; discussion 278\u2013284 (1995).","DOI":"10.1016\/0197-4580(95)00021-6"},{"key":"30779_CR34","unstructured":"Team, R. C. R: A Language and Environment for Statistical Computing (2014)."},{"key":"30779_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder, P. & Horvath, S. WGCNA: an R package for weighted correlation network analysis. BMC bioinformatics 9, 559, https:\/\/doi.org\/10.1186\/1471-2105-9-559 (2008).","journal-title":"BMC bioinformatics"},{"key":"30779_CR36","doi-asserted-by":"crossref","unstructured":"Langfelder, P. & Horvath, S. Fast R Functions for Robust Correlations and Hierarchical Clustering. J Stat Softw 46 (2012).","DOI":"10.18637\/jss.v046.i11"},{"key":"30779_CR37","doi-asserted-by":"publisher","unstructured":"Zhang, B. & Horvath, S. A general framework for weighted gene co-expression network analysis. Statistical applications in genetics and molecular biology 4, Article 17, https:\/\/doi.org\/10.2202\/1544-6115.1128 (2005).","DOI":"10.2202\/1544-6115.1128"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-30779-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-30779-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-30779-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T08:35:28Z","timestamp":1671611728000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-30779-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,17]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["30779"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-30779-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,17]]},"assertion":[{"value":"25 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Within the last 12 months, J.J.I. has served as a consultant to GlaxoSmithKline and a research project in his lab is funded through a Research Collaboration Agreement with GlaxoSmithKline. J.J.I. has served as a paid speaker for Neurim Pharmaceuticals.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"12389"}}